Organ System Involved | Clinical Features | Diagnosis | Treatment and Prognosis |
---|---|---|---|
1. Pulmonary (lung and mediastinal lymph nodes) | -Dyspnea, Cough, Chest pain, Fatigue, Non-productive cough -Constitutional symptoms -rarely, asymptomatic -Underlying Immunodeficiency e.g. AIDS - may clinically mimic pneumonia or interstitial lung disease [5] | -Chest Radiograph-non specific Differential Diagnosis: Pseudolymphoma, Interstitial Pneumonia, Wegener's Granulomatosis, Sarcoidosis, Metastasis [8] -High Resolution CT chest-peribronchovascular distribution of nodules and coarse irregular opacities, small thin walled cysts, and conglomerating small nodules [8] - Gold standard-Histopathology and Immuno-histochemical staining with EBV RNA in situ hybridization. | Progresses to malignant lymphoma in 13-47% cases [3, 8] Mortality ranges from 53-63.5% [3, 8] Treatment modalities-combination chemotherapy, Rituximab, Interferon-α2b, Autologous stem cell transplantation [10–13] |
2. Central Nervous System (in 20% cases) | -Spastic Paraparesis -Gait disturbances -Neurogenic Bladder -Central Diabetes Insipidus -Peripheral neuropathy -Concomitant Pulmonary involvement | -Elevated soluble IL-2 receptor level (normal 167-497 U/ml) -CSF-elevated protein, lymphocytic pleocytosis -MRI-spotty high intensity lesions on T2 imaging and enhancement with gadolinium contrast -PET scan-increased uptake of FDG -Gold standard-Biopsy and immuno-histochemical staining studies, EBV RNA in situ hybridization. | No well established treatment. CNS involvement is a marker of poor prognosis. Whole brain irradiation, chemotherapy, stem cell transplantation tried without much efficacy. Rituximab monotherapy demonstrating efficacy [14]. |
3. Others-skin, liver, kidney, spleen, mesenteric lymph nodes, etc | -Rash, subcutaneous nodules, ulceration. Usually non tender but occasionally pruritic -Usually associated with pulmonary or CNS LG | Work up as above | Treatment is along lines of systemic LG. |